Literature DB >> 22252128

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.

Abhishek D Garg1, Dmitri V Krysko, Tom Verfaillie, Agnieszka Kaczmarek, Gabriela B Ferreira, Thierry Marysael, Noemi Rubio, Malgorzata Firczuk, Chantal Mathieu, Anton J M Roebroek, Wim Annaert, Jakub Golab, Peter de Witte, Peter Vandenabeele, Patrizia Agostinis.   

Abstract

Surface-exposed calreticulin (ecto-CRT) and secreted ATP are crucial damage-associated molecular patterns (DAMPs) for immunogenic apoptosis. Inducers of immunogenic apoptosis rely on an endoplasmic reticulum (ER)-based (reactive oxygen species (ROS)-regulated) pathway for ecto-CRT induction, but the ATP secretion pathway is unknown. We found that after photodynamic therapy (PDT), which generates ROS-mediated ER stress, dying cancer cells undergo immunogenic apoptosis characterized by phenotypic maturation (CD80(high), CD83(high), CD86(high), MHC-II(high)) and functional stimulation (NO(high), IL-10(absent), IL-1β(high)) of dendritic cells as well as induction of a protective antitumour immune response. Intriguingly, early after PDT the cancer cells displayed ecto-CRT and secreted ATP before exhibiting biochemical signatures of apoptosis, through overlapping PERK-orchestrated pathways that require a functional secretory pathway and phosphoinositide 3-kinase (PI3K)-mediated plasma membrane/extracellular trafficking. Interestingly, eIF2α phosphorylation and caspase-8 signalling are dispensable for this ecto-CRT exposure. We also identified LRP1/CD91 as the surface docking site for ecto-CRT and found that depletion of PERK, PI3K p110α and LRP1 but not caspase-8 reduced the immunogenicity of the cancer cells. These results unravel a novel PERK-dependent subroutine for the early and simultaneous emission of two critical DAMPs following ROS-mediated ER stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252128      PMCID: PMC3298003          DOI: 10.1038/emboj.2011.497

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  67 in total

Review 1.  Cancer despite immunosurveillance: immunoselection and immunosubversion.

Authors:  Laurence Zitvogel; Antoine Tesniere; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2006-09-15       Impact factor: 53.106

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

3.  Feed forward cycle of hypotonic stress-induced ATP release, purinergic receptor activation, and growth stimulation of prostate cancer cells.

Authors:  Rajender Nandigama; Manju Padmasekar; Maria Wartenberg; Heinrich Sauer
Journal:  J Biol Chem       Date:  2005-12-01       Impact factor: 5.157

4.  Calreticulin exposure dictates the immunogenicity of cancer cell death.

Authors:  Michel Obeid; Antoine Tesniere; François Ghiringhelli; Gian Maria Fimia; Lionel Apetoh; Jean-Luc Perfettini; Maria Castedo; Grégoire Mignot; Theoharis Panaretakis; Noelia Casares; Didier Métivier; Nathanael Larochette; Peter van Endert; Fabiola Ciccosanti; Mauro Piacentini; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Med       Date:  2006-12-24       Impact factor: 53.440

5.  Mutant Lrp1 knock-in mice generated by recombinase-mediated cassette exchange reveal differential importance of the NPXY motifs in the intracellular domain of LRP1 for normal fetal development.

Authors:  Anton J M Roebroek; Sara Reekmans; Annick Lauwers; Nathalie Feyaerts; Liesbet Smeijers; Dieter Hartmann
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

Review 6.  Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

7.  Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

Authors:  Radek Spisek; Anna Charalambous; Amitabha Mazumder; David H Vesole; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

8.  Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.

Authors:  Shyra J Gardai; Kathleen A McPhillips; S Courtney Frasch; William J Janssen; Anna Starefeldt; Joanne E Murphy-Ullrich; Donna L Bratton; Per-Arne Oldenborg; Marek Michalak; Peter M Henson
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

Review 9.  Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.

Authors:  Esther Buytaert; Michael Dewaele; Patrizia Agostinis
Journal:  Biochim Biophys Acta       Date:  2007-07-06

10.  Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy.

Authors:  Esther Buytaert; Geert Callewaert; Nico Hendrickx; Luca Scorrano; Dieter Hartmann; Ludwig Missiaen; Jackie R Vandenheede; Ingeborg Heirman; Johan Grooten; Patrizia Agostinis
Journal:  FASEB J       Date:  2006-02-02       Impact factor: 5.191

View more
  290 in total

1.  Enlightening the impact of immunogenic cell death in photodynamic cancer therapy.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Guido Kroemer
Journal:  EMBO J       Date:  2012-01-17       Impact factor: 11.598

Review 2.  "Eat me" imaging and therapy.

Authors:  Vaishali Bagalkot; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

3.  Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells.

Authors:  Irena Adkins; Lenka Sadilkova; Nada Hradilova; Jakub Tomala; Marek Kovar; Radek Spisek
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

4.  Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression.

Authors:  Changlin Li; Hui Sun; Wei Wei; Qiuzi Liu; Yinglei Wang; Ying Zhang; Fuming Lian; Fangchao Liu; Chenchen Li; Kaicheng Ying; Hang Huo; Zhi Qi; Benyi Li
Journal:  Cell Oncol (Dordr)       Date:  2020-07-24       Impact factor: 6.730

5.  Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death.

Authors:  Irena Moserova; Iva Truxova; Abhishek D Garg; Jakub Tomala; Patrizia Agostinis; Pierre Francois Cartron; Sarka Vosahlikova; Marek Kovar; Radek Spisek; Jitka Fucikova
Journal:  Oncoimmunology       Date:  2016-11-18       Impact factor: 8.110

6.  Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis.

Authors:  Abhishek D Garg; Dirk De Ruysscher; Patrizia Agostinis
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

7.  Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.

Authors:  Hing-Yuen Yeung; Pui-Chi Lo; Dennis K P Ng; Wing-Ping Fong
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

8.  5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy.

Authors:  Malgorzata Wachowska; Magdalena Gabrysiak; Angelika Muchowicz; Weronika Bednarek; Joanna Barankiewicz; Tomasz Rygiel; Louis Boon; Pawel Mroz; Michael R Hamblin; Jakub Golab
Journal:  Eur J Cancer       Date:  2014-02-18       Impact factor: 9.162

9.  Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells.

Authors:  Donatella D'Eliseo; Laura Manzi; Francesca Velotti
Journal:  Cell Stress Chaperones       Date:  2013-04-12       Impact factor: 3.667

10.  Immunogenic necroptosis in the anti-tumor photodynamic action of BAM-SiPc, a silicon(IV) phthalocyanine-based photosensitizer.

Authors:  Ying Zhang; Ying-Kit Cheung; Dennis K P Ng; Wing-Ping Fong
Journal:  Cancer Immunol Immunother       Date:  2020-08-24       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.